Abilify Lawsuits Alleging Compulsive Gambling May See First Trial This Year

Print

Abilify Lawsuits Allege Plaintiffs Become Compulsive Gamblers And Exhibit Other Impulse Control Disorders After Using Abilify.

abilify-compulsive-gambling-lawsuit-side-effects-lawsuits-bottleThe federal judge managing the Abilify Gambling Lawsuit claims has fast-tracked the pretrial schedule and intends to hold at least one trial by the end of the year. More than 100 Abilfy lawsuit claims pending in the U.S. District Court, Northern District of Florida commonly allege plaintiffs developed an addiction to gambling, shopping, eating and other impulse control disorders after being prescribed the Abilify antipsychotic medication. Otsuka Pharmaceuticals and Bristol-Myers Squibb, which makes and markets Abilify, are named as defendants. (In Re: Abilify (Aripiprazole) Products Liability Litigation – MDL 2734)

In a Case Management Order issued on February 2, U.S. District Judge M. Casey Rodgers, directed the litigation’s Joint Discovery Committee to submit a schedule for the progression of the Abilify cases by February 28. Since the issue of Abilify allegedly causing compulsive behavior is central to the litigation, Judge Rodgers directed the Joint Science and Expert Sub-Committee to submit a proposed schedule for general causation discovery, which includes identifying experts, taking their depositions, and producing expert reports. Judge Rodgers said in her order that she intends to hold a hearing in July and decide on the general causation issue by the end of summer. Judge Rodgers also ordered a full work up of the six cases originally filed in the Northern District of Florida because she wants to hold at least one trial before the year ends. (In Re: Abilify (Aripiprazole) Products Liability Litigation – MDL 2734)

“We are pleased to see that Judge Rodgers intends to fast-track this litigation” says Wright & Schulte LLC. The firm represents men and women who believe they have suffered compilation from antipsychotic drugs and offers free case evaluations to individuals who allegedly sustained significant financial losses and other damages due to an Abilify gambling addiction or other impulse control problems that may be linked to the medication. Please visit our website at www.yourlegalhelp.com or call 1-800-399-0795 to learn more about your potential legal recourse.

Abilify (aripiprazole) is an atypical antipsychotic approved in November 2002 by the U.S. Food and Drug Administration (FDA) to treat schizophrenia, bipolar disorder, Tourette’s disorder, and irritability associated with autistic disorder. Aripiprazole is in a class of drugs called partial dopamine receptor agonists and works somewhat differently than other medicines in its class, according to the FDA. Most atypical antipsychotics more fully block dopamine receptors in the brain, while aripiprazole only partially blocks the activity of these receptors.

In May 2016, the FDA issued a safety announcement warning that compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex have been reported with the use of aripiprazole, which is also sold under the brand names of Abilify Maintena, Aristada, and generics. Since the compulsive behaviors can affect anyone who is prescribed the medication, the FDA added a warning about compulsive behaviors to the drug labels and the patient Medication Guides for all aripiprazole products.
[fda.gov/Drugs/DrugSafety/ucm498662.htm]

Abilify gambling lawsuits indicate 22 complaints were initially transferred to the federal court in Northern Florida in October and consolidated for coordinated pretrial proceedings. In its transfer order that centralized the gambling lawsuits, the U.S. Judicial Panel on Multidistrict Litigation said the lawsuits commonly allege that Abilify was defectively designed or manufactured, and Otsuka Pharmaceuticals and Bristol-Myers Squibb, knew or should have known about the compulsive gambling risk associated with Abilify and failed to provided adequate instructions and warnings about the medication. (In Re: Abilify Gambling Lawsuits (Aripiprazole) Products Liability Litigation – MDL 2734)

Wright & Schulte LLC And Filing An Abilify Gambling Lawsuit

Wright & Schulte LLC is an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, do not hesitate to contact Wright & Schulte LLC today. Free Abilify gambling lawsuit case evaluations are available through yourlegalhelp.com, or call 1-888-399-0795.

Contact:
Wright & Schulte LLC
865 S. Dixie Dr.
Vandalia, Ohio 45377
1-800-399-0795
www.yourlegalhelp.com

This entry was posted in Wright & Schulte Lawsuit News. Bookmark the permalink.